Trial Details
Not RecruitingBasic Information
| Clinical ID | c3214 |
|---|---|
| Identifier | EUCTR2011-003121-94-DK |
| Trial Title | A Prospective, Non-controlled, Safety Study of Intravenous Iron Isomaltoside 1000 (Monofer ® ) administered by a High Dosing Regimen in Subjects with Inflammatory Bowel Disease (PROMISE) - P-Monofer-IBD-02 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease (IBD) MedDRA version: 16.1_Level: LLT_Classification code 10002062_Term: Anaemia iron deficiency_System Organ Class: 100000004851_;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15] |
| Interventions | Trade Name: MonoFer Pharmaceutical Form: Solution for injection/infusion |
Participant Information
| Sponsor | Pharmacosmos A/S |
|---|---|
| City | - |
| Country/Region | Denmark;Netherlands;Sweden |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |